Vitamins that may be helpful
In a preliminary study, individuals with pulmonary hypertension (a life-threatening
complication of sickle cell anemia) received L-arginine in the amount of 100 mg per 2.2 pounds of
body weight, three times per day for five days. L-arginine treatment resulted in a significant
improvement in pulmonary hypertension, as determined by a 15% decline in the pulmonary artery
systolic pressure.4 Longer-term studies are needed to confirm these preliminary
results.
Sickle cell anemia may result in vitamin
B12 deficiency. A study of children with sickle cell anemia found them to have a higher
incidence of vitamin B12 deficiency than children without the disease.5 A study of
85 adults with sickle cell anemia showed more of them had vitamin B12 deficiency than did a
group of healthy people.6 A subsequent preliminary trial demonstrated that for
patients with low blood levels of vitamin B12, intramuscular injections of 1 mg of vitamin B12
weekly for 12 weeks led to a significant reduction in symptoms.7 Researchers do not
know whether people with sickle cell anemia who are found to be deficient in vitamin B12 would
benefit equally from taking vitamin B12 supplements orally.
In a preliminary trial, 20 patients with sickle cell anemia were given either 1 mg of folic acid per day or folic acid plus 6 grams of
aged garlic extract, 6 grams of vitamin C, and
1,200 mg of vitamin E per day for six months.8 Patients taking the combination had
a significant improvement in their hematocrit (an index of anemia) and less painful crises
than those taking just folic acid.
Preliminary research has found that patients with sickle cell anemia are more likely to
have elevated blood levels of homocysteine
compared to healthy people.9 10 Elevated homocysteine is recognized as a
risk factor for cardiovascular
disease.11 In particular, high levels of homocysteine in sickle cell anemia
patients have been associated with a higher incidence of stroke.12 Deficiencies of vitamin B6, vitamin B12, and folic acid occur more
frequently in people with sickle cell anemia than in others13 14
15 and are a cause of high homocysteine levels.16 A controlled trial found
homocysteine levels were reduced 53% in children with sickle cell anemia receiving a 2–4
mg supplement of folic acid per day, depending on age, but vitamin B6 or B12 had no effect on
homocysteine levels.17 A double-blind trial of children with sickle cell anemia
found that children given 5 mg of folic acid per day had less painful swelling of the hands
and feet compared with those receiving placebo, but blood abnormalities and impaired growth
rate associated with sickle cell anemia were not improved.18 In the treatment of
sickle cell anemia, folic acid is typically supplemented in amounts of 1,000 mcg
daily.19 Anyone taking this amount of folic acid should have vitamin B12 status
assessed by a healthcare professional.
Iron deficiency is relatively common in
people with sickle cell anemia, especially in
pregnant women and in children.20 21 Iron deficiency in people with
sickle cell anemia is best diagnosed with a laboratory test called serum
ferritin.22 23 During sickle cell crises, however, serum ferritin is no
longer useful as an indicator of iron deficiency.24 The value of iron supplementation for people with sickle cell
anemia who are diagnosed with iron deficiency is unclear. Iron supplements have, in some
reports, reduced the severity of anemia as measured by laboratory tests; however, some reports
suggest they may increase the symptoms of sickle cell anemia.25 26
Moreover, a state of iron deficiency has been shown to reduce sickling of red blood cells in
the blood of people with sickle cell anemia.27 A small trial of iron
restriction in patients with sickle cell anemia found improvement in anemia and clinical
symptoms as well as decreased red blood cell breakdown during iron restriction.28 A
doctor should be consulted before deciding to supplement or restrict iron in sickle cell
anemia.
Low concentrations of red blood cell magnesium have been noted in patients with sickle cell
anemia.29 30 Low magnesium, in turn, is thought to contribute to red
blood cell dehydration and a concomitant increase in symptoms. In a preliminary trial,
administration of 540 mg of magnesium per day
for six months to sickle cell anemia patients reversed some of the characteristic red blood
cell abnormalities and dramatically reduced the number of painful days for these
patients.31 The form of magnesium used in this trial, magnesium pidolate, is not
supplied by most magnesium supplements; it is unknown whether other forms of magnesium would
produce similar results.
In test tube studies, vitamin B6 has been
shown to have anti-sickling effects on the red blood cells of people with sickle cell
anemia.32 33 Vitamin B6 deficiency has been reported in some research to
be more common in people with sickle cell anemia than in healthy people.34
35 In a controlled trial, five sickle cell anemia patients with evidence of vitamin B6
deficiency were given 50 mg of vitamin B6 twice daily. The deficiency was reversed with this
supplement, but improvement in anemia was slight and considered insignificant.36
Therefore, evidence in support of vitamin B6 supplementation for people with sickle cell
anemia remains weak.
Antioxidant nutrients protect the
body’s cells from oxygen-related damage. Many studies show that sickle cell anemia
patients tend to have low blood levels of antioxidants, including carotenoids, vitamin A, vitamin E, and vitamin C, despite adequate intake.37
38 39 40 41 42 Low blood levels of vitamin E
in particular have been associated with higher numbers of diseased cells in
children43 and with greater frequency of symptoms in adults.44 A small,
preliminary trial reported a 44% decrease in the average number of diseased cells in six
sickle cell anemia patients given 450 IU vitamin E per day for up to 35 weeks. This effect was
maintained as long as supplementation continued.45
In another preliminary trial, 13 patients with sickle cell anemia were given two supplement
combinations for seven to eight months each. The first combination included 109 mg zinc, 153 IU vitamin E, 600 mg vitamin C, and 400 ml (about 14 ounces) of soybean oil
containing 11 grams of linoleic acid and 1.5 grams of alpha linolenic acid. The second
combination included 140 IU vitamin E, 600 mg vitamin C, and 20 grams of fish oil containing 6 grams of omega-3 fatty acids.
Reduction in diseased cells was observed only during the administration of the first protocol.
The authors concluded that zinc was the important difference between the two combinations and
may be a protector of red blood cell membranes.46
Fish oil alone has also been studied. In a
double-blind trial, supplementation with menhaden oil, in the amount of 250 mg per 2.2 pounds
of body weight per day for one year, reduced the frequency of severe pain episodes by
approximately 45%, compared with placebo.47 This treatment may work by correcting
an imbalance between omega-3 and omega-6 fatty acids that occurs in people with sickle cell
anemia.48
The zinc deficiency associated with sickle cell anemia appears to play a role in various
aspects of the illness. For example, preliminary research has correlated low zinc levels with
poor growth in children with sickle cell anemia.49 In a preliminary trial, 12
people with sickle cell anemia received 25 mg of zinc every four hours for 3 to 18
months.50 The number of damaged red blood cells fell from 28% to 18.6%. Addition of
2 mg of copper per day did not inhibit the effect of zinc. (Zinc supplementation in the
absence of copper supplementation induces a copper deficiency.) Patients with the highest
number of damaged red blood cells had a marked response to zinc, but those with lower levels
of damaged cells (less than 20% irreversibly sickled cells) had little or no response. Chronic
leg ulcers occur in about 75% of adults with sickle cell disease. In a controlled trial,
sickle cell patients with low blood levels of zinc received 88 mg of zinc three times per day
for 12 weeks.51 Ulcer healing rate was more than three times faster in the zinc
group than in the placebo group.
Are there any side effects or interactions?
Refer to the individual supplement for information about any side effects or interactions.
1. Tangney CC, Phillips G, Bell RA, et al. Selected indices of
micronutrient status in adult patients with sickle cell anemia (SCA). Am J Hematol
1989;32:161–6.
2. Phillips G, Tangney CC. Relationship of plasma alpha tocopherol to
index of clinical severity in individuals with sickle cell anemia. Am J Hematol
1992;41:227–31.
3. Chiu D, Vichinsky E, Ho SL, et al. Vitamin C deficiency in patients
with sickle cell anemia. Am J Pediatr Hematol Oncol 1990;12:262–7.
4. Morris CR, Morris SM Jr, Hagar W, et al. Arginine therapy: a new
treatment for pulmonary hypertension in sickle cell disease? Am J Respir Crit Care
Med 2003;168:63–9.
5. Osifo BO, Adeyokunnu A, Parmentier Y, et al. Abnormalities of serum
transcobalamins in sickle cell disease (HbSS) in Black Africa. Scand J Haematol
1983;30:135–40.
6. al-Momen AK. Diminished vitamin B12 levels in patients with severe
sickle cell disease. J Intern Med 1995;237:551–5.
7. al-Momen AK. Diminished vitamin B12 levels in patients with severe
sickle cell disease. J Intern Med 1995;237:551–5.
8. Ohnishi ST, Ohnishi T, Ogunmola GB. Sickle cell anemia: A potential
nutritional approach for a molecular disease. Nutrition 2000;16:330–8.
9. van der Dijs FP, Schnog JJ, Brouwer DA, et al. Elevated homocysteine
levels indicate suboptimal folate status in pediatric sickle cell patients. Am J
Hematol 1998;59:192–8.
10. Houston PE, Rana S, Sekhasaria S, et al. Homocysteine in sickle cell
disease: relationship to stroke. Am J Med 1997;103:192–6.
11. Alpert MA. Homocysteine, atherosclerosis, and thrombosis. South
Med J 1999;92:858–65 [review].
12. Houston PE, Rana S, Sekhasaria S, et al. Homocysteine in sickle cell
disease: relationship to stroke. Am J Med 1997;103:192–6.
13. al-Momen AK. Diminished vitamin B12 levels in patients with severe
sickle cell disease. J Intern Med 1995;237:551–5.
14. Lin YK. Folic acid deficiency in sickle cell anemia. Scand J
Haematol 1975;14:71–9.
15. Natta CL, Reynolds RD. Apparent vitamin B6 deficiency in sickle cell
anemia. Am J Clin Nutr 1984;40:235–9.
16. Alpert MA. Homocysteine, atherosclerosis, and thrombosis. South
Med J 1999;92:858–65 [review].
17. van der Dijs FP, Schnog JJ, Brouwer DA, et al. Elevated homocysteine
levels indicate suboptimal folate status in pediatric sickle cell patients. Am J
Hematol 1998;59:192–8.
18. Rabb LM, Grandison Y, Mason K, et al. A trial of folate
supplementation in children with homozygous sickle cell disease. Br J Haematol
1983;54:589–94.
19. Waterbury L. Anemia. In Barker LR, Burton JR, Zieve PD.
Principles of ambulatory medicine, 4th ed. Baltimore: Williams & Wilkins, 1995,
605.
20. Pellegrini Braga JA, Kerbauy J, Fisberg M. Zinc, copper and iron and
their interrelations in the growth of sickle cell patients. Arch Latinoam Nutr
1995;45:198–203.
21. Reed JD, Redding-Lallinger R, Orringer EP. Nutrition and sickle cell
disease. Am J Hematol 1987;24:441–55 [review].
22. Vichinsky E, Kleman K, Embury S, Lubia B. The diagnosis of
iron-deficiency anemia in sickle cell disease. Blood 1981;58:963–8.
23. Rao KR, Patel AR, McGinnis P, Patel MK. Iron stores in adults with
sickle cell anemia. J Lab Clin Med 1984;103:792–7.
24. Brownell A, Lawson S, Bozovic M. Serum ferritin concentration in
sickle cell crisis. J Clin Pathol 1986;39:253–5.
25. Vichinsky E, Kleman K, Embury S, Lubia B. The diagnosis of
iron-deficiency anemia in sickle cell disease. Blood 1981;58:963–8.
26. Haddy TB, Castro O. Overt iron deficiency in sickle cell disease.
Arch Int Med 1982;142:1621–4.
27. Rao KR, Patel ER, Honig GR, et al. Iron deficiency and sickle cell
anemia. Arch Int Med 1983;143:1030–2.
28. Castro O, Poillon WN, Finkle H, Massac E. Improvement of sickle cell
anemia by iron-limited erythropoiesis. Am J Hematol 1994;47:74–81.
29. De Franceschi L, Bachir D, Galacteros F, et al. Oral magnesium
pidolate: effects of long-term administration in patients with sickle cell disease. Br J
Haematol 2000;108:284–9.
30. De Franceschi L, Bachir D, Balacteros F, et al. Oral magnesium
supplements reduce erythrocyte dehydration in patients with sickle cell disease. J Clin
Invest 1997;100:1847–52.
31. De Franceschi L, Bachir D, Galacteros F, et al. Oral magnesium
pidolate: effects of long-term administration in patients with sickle cell disease. Br J
Haematol 2000;108:284–9.
32. Kark JA, Kale MP, Tarassoff PG, et al. Inhibition of erythrocyte
sickling in vitro by pyridoxal. J Clin Invest 1978;62:888–91.
33. Kark JA, Tarassoff PG, Bongiovanni R. Pyridoxal phosphate as an
antisickling agent in vitro. J Clin Invest 1983;71:1224–9.
34. Flores L, Pais R, Buchanan I, et al. Pyridoxal 5’-phosphate
levels in children with sickle cell disease. Am J Pediatr Hematol Oncol
1988;10:236–40.
35. Reed JD, Redding-Lallinger R, Orringer EP. Nutrition and sickle cell
disease. Am J Hematol 1987;24:441–55.
36. Natta CL, Reynolds RD. Apparent vitamin B6 deficiency in sickle cell
anemia. Am J Clin Nutr 1984;40:235–9.
37. Tangney CC, Phillips G, Bell RA, et al. Selected indices of
micronutrient status in adult patients with sickle cell anemia (SCA). Am J Hematol
1989;32:161–6.
38. Chiu D, Vichinsky E, Ho SL, et al. Vitamin C deficiency in patients
with sickle cell anemia. Am J Pediatr Hematol Oncol 1990;12:262–7.
39. Jain SK, Ross JD, Duett J, Herbst JJ. Low plasma prealbumin and
carotenoid levels in sickle cell disease patients. Am J Med Sci
1990;229:13–5.
40. Jain SK, Williams DM. Reduced levels of plasma ascorbic acid (vitamin
C) in sickle cell disease patients: its possible role in the oxidant damage to sickle cells in
vitro. Clin Chim Acta 1985;149:257–61.
41. Natta C, Stacewicz-Sapuntzakis M, Bhagavan H, Bowen P. Low serum
levels of carotenoids in sickle cell anemia. Eur J Haematol 1988;41:131–5.
42. Essein, EU. Plasma levels of retinol, ascorbic acid and
alpha-tocopherol in sickle cell anemia. Centr Afr J Med 1995;41:48–50.
43. Ndombi IO, Kinoti SN. Serum vitamin E and the sickling status in
children with sickle cell anemia. East Afr Med J 1990;67:720–5.
44. Phillips G, Tangney CC. Relationship of plasma alpha tocopherol to
index of clinical severity in individuals with sickle cell anemia. Am J Hematol
1992;41:227–31.
45. Natta CL, Machlin LJ, Brin M. A decrease in irreversibly sickled
erythrocytes in sickle cell anemia patients given vitamin E. Am J Clin Nutr
1980;33:968–71.
46. Muskiet FA, Muskiet FD, Meiborg G, Schermer JG. Supplementation of
patients with homozygous sickle cell disease with zinc, alpha-tocopherol, vitamin C, soybean
oil, and fish oil. Am J Clin Nutr 1991;54:736–44.
47. Tomer A, Kasey S, Connor WE, et al. Reduction of pain episodes and
prothrombotic activity in sickle cell disease by dietary n-3 fatty acids. Thromb
Haemost 2001;85:966–74.
48. Tomer A, Kasey S, Connor WE, et al. Reduction of pain episodes and
prothrombotic activity in sickle cell disease by dietary n-3 fatty acids. Thromb
Haemost 2001;85:966–74.
49. Pellegrini Braga JA, Kerbauy J, Fisberg M. Zinc, copper and iron and
their interrelations in the growth of sickle cell patients. Arch Latinoam Nutr
1995;45:198–203.
50. Brewer GJ, Brewer LF, Prasad AS. Suppression of irreversibly sickled
erythrocytes by zinc therapy in sickle cell anemia. J Lab Clin Med
1977;90:549–54.
51. Serjeant GR, Galloway RE, Gueri MC. Oral zinc sulphate in sickle-cell
ulcers. Lancet 1970;2:891–3.